Anaergia (ANRG) Q2 2025 earnings summary

Executive summary

• Revenue increased 36.8% year-over-year to $32.3 million in Q2 2025, driven by higher Capital Sales in North America and Italy and improved operational efficiency under the Anaergia 2.0 transformation.

• Gross profit margin rose to 32.5% from 17.6% year-over-year, reflecting improved margins across all segments.

• Revenue backlog reached $243.9 million as of June 30, 2025, up 137% from year-end, indicating strong customer demand and market confidence.

• The company is executing a strategic shift to a capital-light, scalable business model, enhancing profitability and growth prospects across geographies and project sizes.

• Expanded agreements and repeat business in Europe and North America, with new long-term supply contracts and strategic partnerships, highlight growing market traction.

Financial highlights

• Q2 2025 revenue was $32.3 million, up 36.8% year-over-year and 30% sequentially, with gross profit of $10.5 million, a 152.9% increase year-over-year.

• Gross margin improved to 32.5%, up 14.9 percentage points from Q2 2024.

• SG&A expenses decreased 3.7% to $14.3 million, reflecting ongoing cost control.

• Net loss improved to $9.5 million, a 29% reduction from Q2 2024.

• Adjusted EBITDA loss narrowed to $2.2 million, a 72.1% improvement year-over-year.

Outlook and guidance

• Backlog as of June 30, 2025, was $243.9 million, up 137% from year-end, providing strong visibility into future revenue.

• Additional $43.8 million in new capital sales contracts signed since quarter-end, driven by demand in Italy and North America.

• Management expresses optimism for future growth, citing robust market and regulatory tailwinds and a focus on profitable growth and disciplined execution.

• Multi-year revenue expected from new and expanded contracts in Europe and Asia.